Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts

CardioVascular and Interventional Radiology

Volumn 29, Issue 5, 2006, Pages 778-784

  Tesdal, I Kaare ^a,b   Wikström, Mats ^a,b   Flechtenmacher, Christa ^c   Filser, Thomas ^a   Dueber, Christoph ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Klinikum Friedrichshafen   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Hepatocellular carcinoma; Liver, cirrhosis; Percutaneous ethanol injection; Shunts, portosystemic; Transarterial chemoembolization

Indexed keywords

ALCOHOL; EPIRUBICIN; IODINATED POPPYSEED OIL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRAIN DISEASE; CATHETERIZATION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; PERITONITIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; EPIRUBICIN; ETHANOL; FEMALE; HUMANS; HYPERTENSION, PORTAL; INJECTIONS; IODIZED OIL; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC;

EID: 33746458970     PISSN: 01741551     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00270-005-0063-7     Document Type: Article

References (35)

1. Koteish A, Thuluvath PJ (2002) Screening for hepatocellular carcinoma. J Vasc Interv Radiol 13:185-190
2. El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745-750
3. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA (2003) The continuing increase in the incidence of hepatocellular carcinoma in the United States: An update. Ann Intern Med 139:817-823
4. Camma C, Schepis F, Orlando A, Albanase M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials. Radiology 224:47-54
5. Myers RP (2003) Meta-analysis of transarterial embolization in patients with unresectable hepatocellular carcinoma. Radiology 227:611-612
6. Ho J, Wu PC, Kung TM (1981) An autopsy study of hepatocellular carcinoma in Hong Kong. Pathology 13:409-415
7. Sakaguchi H, Uchida H, Maeda M, Matsuo N, Kichikawa K, Ohishi H, Nishida H, Ueno K, Nishimine K, Rosch J (1995) Combined transjugular intrahepatic portosystemic shunt and segmental lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: Preliminary report. Cardiovasc Intervent Radiol 18:9-15
8. Mingoli A, Modini C, Salvatori F, Bezzi M, Sgarzini G, Nardacchione F, Marzano M (1995) Emergency transjugular intrahepatic portosystemic shunt in patients with variceal bleeding and hepatocellular carcinoma. Ital J Gastroenterol 27:309-312
9. Serafini FM, Zwiebel B, Black TJ, Carey LC, Rosemurgy AS (1997) Transjugular intrahepatic portasystemic stent shunt in the treatment of variceal bleeding in hepatocellular carcinoma. Dig Dis Sci 42:59-65
10. Tazawa J, Sakai Y, Yamana M, Kakinuma S, Maeda M, Suzuki K, Miyasaka Y, Nagayama K, Kusano F, Sato C (2000) Long-term observation after transjugular intrahepatic portosystemic stent shunt in two patients with hepatocellular carcinoma. J Clin Gastroenterol 31:262-267
11. Pugh RNH, Murray-Lyon M, Dawson JL, Pietroni MC, Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 8:646-649
12. Rössle M, Haag K, Ochs A, Sellinger M, Nöldge G, Perarnau J-M, Berger E, Blum U, Gabelmann A, Hauenstein KH, Langer M, Gerok W (1994) The transjugular intrahepatic portosystemic shunt. N Engl J Med 330:165-171
13. Tesdal IK, Jaschke W, Bühler M, Adamus R, Filser T, Holm E, Georgi M (1997) Transjugular intrahepatic portosystemic shunting (TIPS) with balloon-expandable and self-expanding stents: Technical and clinical aspects after 3 1/2 years experience. Cardiovasc Intervent Radiol 20:29-37
14. International Union Against Cancer (1998). TNM atlas 4th ed. Berlin Heidelberg New York: Springer, pp 115-123
15. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K (1985) Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 56:918-928
16. Adamus R, Tesdal IK, Georgi M (1997) Perkutane Alkoholinstillationstherapie (PAI) und Chemoembolisation bei einem ausgedehnten hepatozellulären Karzinom (HCC). Fortschr Rontgenstr 166:173-175
17. Bruix J, Sherman M, Llovet JM, et al. (2001) for the EASL Panel of Experts on HCC Clinical management of hepatocellular carcinoma: Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35:421-430
18. Häussler MD, Pfeifer T, Safi F, Friedrich JM, Bargon G (1993). CT-Monitoring bei regionaler Chemotherapie von Lebermetastasen. In: Reiser M, Streudel A, Hirner A, Kania U (eds). Lebertumoren und portale Hypertension: Radiologische und chirurgische Aspekte. Berlin Heidelberg New York: Springer, pp 241-247
19. Shiffman ML, Jeffers L, Hoofnagle JH, Tralka TS (1995) The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the National Digestive Diseases Advisory Board. Hepatology 22:1591-1597
20. Haskal ZJ, Martin L, Cardella JF, Cole PE, Drooz A, Grassi CJ, McCowan TC, Meranze SG, Neithamer CD, Oglevie SB, Roberts AC, Sacks D, Silverstein MI, Swan TL, Towbin RB, Lewis CA (2001) Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of practice committee. J Vasc Interv Radiol 12:131-136
21. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871
22. Hidajat N, Vogl T, Stobbe H, Schmidt J, Wex C, Lenzen R, Berg T, Neuhaus P, Felix R (2000) Transjugular intrahepatic portosystemic shunt. Experience at a liver transplantation center. Acta Radiol 41:474-478
23. Wallace M, Swaim M (2003) Transjugular intrahepatic portosystemic shunts through hepatic neoplasms. J Vasc Interv Radiol 14:501-507
24. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, Sala M, Muchart J, Sola R, Rodes J, Bruix J (2002) Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomized, controlled trial. Lancet 359:1734-1739
25. LO CH, Ngan H, Tso W-K, Liu C-L, Lam C-M, Poon RT-P, Fan S-T, Wong J (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164-1171
26. Ramsey DE, Kernagis LY, Soulen MC, Geschwind JFH (2002) Chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol 13:211-221
27. Huppert PE, Lauchart W, Duda SH, Torkler C, Kloska SP, Weinlich M, Benda N, Pereira P, Claussen CD (2004) Chemoembolisation des hepatozellulären Karzinoms: Welche Faktoren bestimmen Therapieansprechen und Überleben? Fortschr Rontgenstr 176:375-385
28. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, Torzilli G (1995) No treatment, resection and ethanol injection in hepatocellular carcinoma: A retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 22:522-526
29. Lencioni RL, Allgaier H-P, Cioni D, Olschewski M, Deibert P, Crocetti L, Frings H, Laubenberger J, Zuber I, Blum HE, Bartolozzi C (2003) Small hepatocellular carcinoma in cirrhosis: Randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235-240
30. Bartoluzzi C, Lencioni R (1996) Ethanol injection for the treatment of hepatic tumors. Eur Radiol 6:682-696
31. Bartolozzi C, Lencioni R, Caramella D, Vignali C, Cioni R, Mazzeo S, Carrai M, Maltinti G, Capria A, Conte PF (1995) Treatment of large HCC: Transcatheter arterial embolization combined with PEI versus repeated TACE. Radiology 197:812-818
32. Dohmen K, Shirahama M, Shigematsu H, Miyamoto Y, Torii Y, Irie K, Ishibashi H (2001) Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: An evaluation of the local therapeutic effect and survival rate. Hepatogastroenterology 48:1409-1415
33. Koda M, Murawaki Y, Mitsuda A, Mitsuda A, Oyama K, Okamoto K, Idobe Y, Suou T, Kawasaki H (2001) Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: A randomized controlled study. Cancer 92:1516-1524
34. Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW (2004) Langzeitergebnisse der interventionellen Therapie von großen, inoperablen hepatozellulären Karzinome (HCC): signifikanter Überlebnsvorteil von transarterieller Chemoembolisation (TACE) und perkutaner Ethanolinjektion (PEI) gegenüber der TACE-Monotherapie. Fortschr Rontgenstr 176:1794-1802
35. Acunas B, Rozanes I (1999) Hepatocellular carcinoma: Treatment with transcatheter arterial chemoembolization. Eur J Radiol 32:86-89